LOGIN  |  REGISTER
Amneal Pharmaceuticals
Compass Therapeutics

Neogen® Releases CelluSmart Technology for Biofuel Industry

June 07, 2024 | Last Trade: US$12.04 0.02 0.17

LANSING, Mich., June 7, 2024 /PRNewswire/ -- Neogen® Corporation (NASDAQ: NEOG), an innovative leader in food safety solutions, announced today that it has launched the new CelluSmart technology from Megazyme® by Neogen for the measurement of cellulosic ethanol from biofuel production.

In creating this industry-first technology, Neogen improved upon the previous National Renewable Energy Laboratory (NREL) procedure, introducing a yeast-degrading cocktail (YDC). With these improvements, CelluSmart allows the ethanol industry to fully realize its efforts to produce low-carbon fuels, represented in value by the D3 RINs generated from in-situ production.

Cellulosic ethanol represents a 60% reduction in greenhouse gas emissions from standard petroleum-based fuel and helps progress toward climate goals. The CelluSmart technology has the potential to help ethanol producers further reduce carbon intensity scores, which, in combination with other factors, may help them gain access to new markets, including sustainable aviation fuel.

"The ethanol industry is a success story in providing low-carbon renewable energy," said John Adent, Neogen's President and Chief Executive Officer. "With the new CelluSmart technology, we can continue to leverage our knowledge in fiber and carbohydrate method development to contribute to the growth of this industry and help create a more sustainable world."

"Neogen is a long-term partner with the biofuel industry, and we have worked together in the food safety space over the years," said Dr. Jason Lilly, Vice President of the Americas and Australia/New Zealand at Neogen. "We are thrilled to provide producers with this highly requested technology and strengthen our relationship with the industry as we strive to enable a more sustainable future." 

The CelluSmart technology is incorporated into ASTM Method E-3417-24, which meets the U.S. Environmental Protection Agency's (EPA) requirements for an approved method from a voluntary consensus standards body.

About Neogen

Neogen Corporation is committed to fueling a brighter future for global food security through the advancement of human and animal well-being. Harnessing the power of science and technology, Neogen has developed comprehensive solutions spanning the Food Safety, Livestock, and Pet Health & Wellness markets. A world leader in these fields, Neogen has a presence in over 140 countries with a dedicated network of scientists and technical experts focused on delivering optimized products and technology for its customers.

Contact

This email address is being protected from spambots. You need JavaScript enabled to view it. 

Assertio

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

C4 Therapeutics

C4 Therapeutics is pioneering a new class of small-molecule drugs that selectively destroy disease-causing proteins via degradation using the innate machinery of the cell. This targeted protein degradation approach offers advantages over traditional drugs, including the potential to treat a wider range of diseases...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB